Publication | Open Access

Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II–III Resectable Disease

Tumor ImmunologyCancer ImmunosurveillanceMedicineMelanomaImmunologyTumor ImmunityPathologyImmune SurveillanceImmune Gene NetworksImmunotherapeuticsAntitumor SurveillanceImmunotherapyOncology